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Purpose: The aim of this study was to identify the genes and pathways underlying the growth of the mouse sclera during
postnatal development.
Methods: Total RNA was isolated from each of 30 single mouse sclera (n=30, 6 sclera each from 1-, 2-, 3-, 6-, and 8-
week-old mice) and reverse-transcribed into cDNA using a T7-N6 primer. The resulting cDNA was fragmented, labeled
with biotin, and hybridized to a Mouse Gene 1.0 ST Array. ANOVA analysis was then performed using Partek Genomic
Suite 6.5 beta and differentially expressed transcript clusters were filtered based on a selection criterion of ≥2 relative fold
change at a false discovery rate of ≤5%. Genes identified as involved in the main biologic processes during postnatal
scleral development were further confirmed using qPCR. A possible pathway that contributes to the postnatal development
of the sclera was investigated using Ingenuity Pathway Analysis software.
Results: The hierarchical clustering of all time points showed that they did not cluster according to age. The highest
number of differentially expressed transcript clusters was found when week 1 and week 2 old scleral tissues were compared.
The peroxisome proliferator- activated receptor gamma coactivator 1-alpha (Ppargc1a) gene was found to be involved in
the networks generated using Ingenuity Pathway Studio (IPA) from the differentially expressed transcript cluster lists of
week 2 versus 1, week 3 versus 2, week 6 versus 3, and week 8 versus 6. The gene expression of Ppargc1a varied during
scleral growth from week 1 to 2, week 2 to 3, week 3 to 6, and week 6 to 8 and was found to interact with a different set
of genes at different scleral growth stages. Therefore, this indicated that Ppargc1a might play a role in scleral growth
during postnatal weeks 1 to 8.
Conclusions: Gene expression of eye diseases should be studied as early as postnatal weeks 1–2 to ensure that any changes
in gene expression pattern during disease development are detected. In addition, we propose that Ppargc1a might play a
role in regulating postnatal scleral development by interacting with a different set of genes at different scleral growth
stages.
The sclera is a fibrous connective tissue consisting of
90% collagen and a small percentage of proteoglycans and
glycoproteins. Collagen fibrils of the sclera are arranged in
layers (lamellae) and are relatively similar to the collagen
arrangement of the cornea [1]. The sclera forms the major
component of the ocular outer coat and is continuous with the
cornea  anteriorly  [2].  Its  main  function  is  to  protect  the
delicate intraocular structures, maintain the optical path for
retinal  imaging,  overcome  the  intraocular  pressure  and
preserve the ocular dimensions by controlling the size of the
eye [3,4].
The mouse eye is not fully developed at birth. After birth,
the  mouse  eye  remains  closed  until  approximately  10–14
days, after which eyelid adhesions break down through the
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processes of apoptosis and necrosis [5]. As the mouse eye
develops,  adaptive  changes  occur  in  response  to  light
exposure and environmental changes.
The corneal stroma and sclera consist of few fibroblasts
and large amounts of extracellular matrix (ECM). In general,
mRNA levels of ECM and collagen genes have been found to
be  downregulated  in  both  the  adult  mouse  sclera  [6]  and
cornea  [7]  when  compared  with  samples  from  an  earlier
developmental stage. Also, in a paper by Zhou et al. [6], the
transforming growth factor beta 1 (Tgfβ1) gene and several
collagen genes were significantly downregulated in 8-week-
old B6 mice scleras when compared with 3-week-old B6 mice
scleras. It was suggested that Tgfβ1 could possibly act as a
signaling molecule in controlling collagen gene expression
and modulate ECM during ocular growth. On the other hand,
components  of  ECM  have  been  found  to  be  continually
synthesized and accumulated throughout postnatal growth,
such as the concentration of scleral proteoglycans, which have
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1436been found to increase steadily in humans from childhood to
the fourth decade of life [8].
As  the  sclera  plays  several  pivotal  functions  in  eye,
understanding  the  mechanism  of  post-natal  sclera
development will shed light to the pathogenesis of disorders
found in sclera as well as other ocular tissues. The mouse
genome bears 85% homology to the human genome and has
been completely sequenced [9]. Thus, the use of the mouse
model has advantages over other animal models, given that
we would like to study genetic expression patterns in the
mouse  sclera  tissue  to  gain  an  understanding  of  human
postnatal scleral gene expression. Although there have been
studies conducted on the developmental growth of the cornea,
there are relatively few gene expression studies documenting
expression patterns in postnatal mouse sclera. In a previous
study on postnatal scleral growth by Zhou et al. [6], total RNA
was extracted from pooled mouse sclera (18 samples each
from 3- and 8-week-old mice 6, per array chip), converted to
biotin labeled cRNA and hybridized to GeneChip® Mouse
Genome 430 2.0 Array chips (3′-based expression arrays). The
expression of 8 extracellular matrix related genes were then
confirmed  using  real  time  PCR.  In  our  experiment,  we
included more time points (namely weeks 1, 2, 3, 6, and 8) to
provide  a  more  comprehensive  overview  of  sclera  gene
expression  profiles  during  postnatal  development.
Additionally, we used GeneChip® Mouse Gene 1.0 ST Arrays
that provide better coverage and a more accurate view of the
total  transcription  at  each  genomic  locus  than  3′-based
expression array designs do. We also identified pathways
underlying the postnatal scleral development using Ingenuity
Pathway Analysis software (IPA). Furthermore, RNA from a
single sclera was isolated for each gene array to allow the
detection  of  the  differences  that  exist  between  individual
samples. Using high-throughput microarray technology to do
gene  profiling  (genome  wide  expression  analysis)  and
pathway analysis, we hope to further understand the gene
expression  profiles  and  identify  a  signaling  pathway  that
occurs in sclera during postnatal development.
METHODS
Animals and tissue collection: Balb/cJ mice (Mus musculus)
were obtained from the animal holding unit of the National
University of Singapore. Approval was obtained from the
SingHealth  Institute  Animal  Care  and  Use  Committee
(IACUC, AAALAC accredited) and all aspects of this study
were performed according to the Association for Research in
Vision  and  Ophthalmology  (ARVO)  Protocol  for  animal
experimentation. In this study, animals belonging to the same
family were used. This was done to minimize changes in gene
expression patterns due to differences in genetic background.
A single sclera was collected from one mouse (n=30, 6 single
sclera from 6 individual mice, 6 mice per time point at week
1, 2, 3, 6, and 8) for each microarray. Principal component
analysis (PCA analysis) of microarray results showed little
variation among the samples from each week. As a single
sclera provides insufficient yields of RNA to confirm the
microarray results, sclera from 6 additional individual mice
were pooled and subsequently converted to cDNA for the
expression analysis of a group of genes.
RNA, target cDNA and microarray chip preparation: Total
RNA was isolated from single cryogenically ground mouse
sclera (n=30, 6 samples each from 1-, 2-, 3-, 6-, and 8-week-
old mice) using the MELTTM Total Nucleic Acid Isolation
System  (Ambion  Inc.,  Austin,  TX)  according  to  the
manufacturer’s instructions. RNA concentration and quality
was assessed by absorbance at 260 nm and the absorbance
ratio  of  260/280  using  a  Nanodrop®  ND-1000
Spectrophotometer  (Nanodrop  Technologies,  Wilmington,
DE). The extracted RNA was then reverse-transcribed into
sense cDNA using a T7-N6 primer and labeled with biotin
using a Genechip® Whole Transcript Sense Target Labeling
Assay (Affrymetrix, Inc., Santa Clara, CA). Biotin-labeled
cDNA were then hybridized to a Mouse Gene 1.0 ST Array
(Affrymetrix,  Inc.)  using  a  Genechip®  Hybridzation  Kit
(Affrymetrix, Inc.). The microarray chips were washed and
stained using a Genechip® Hybridzation, Wash and Stain Kit
(Affrymetrix, Inc.). Subsequently, the microarray chips were
scanned using a Genechip® Scanner 3000 7G (Affrymetrix,
Inc.).
Microarray data analysis: The microarray gene expression
data  was  analyzed  using  Partek  Genomic  Suite  6.5  beta
software (Partek Inc., Louis, MO). Briefly, the data (cel.files)
was  imported  and  normalized  using  robust  multiarray
averaging (RMA). The data discussed in this publication has
been deposited in NCBI’s Gene Expression Omnibus (GEO)
and  is  accessible  through  GEO  Series  accession  number
GSE28056.
The samples were assessed for batch effects and further
normalized by the batch removal tool using scan date as a
factor. ANOVA was then performed to identify significant
differentially  expressed  transcript  clusters.  The  lists  of
differentially  expressed  transcript  clusters  between  age
groups  were  filtered  based  on  a  selection  criterion  of  ≥2
relative fold change at a false discovery rate of ≤5% (the lists
of the differentially expressed transcript clusters between age
groups can be found in Appendix 1).
Subsequently,  the  list  of  differentially  expressed
transcript clusters for week 2 versus 1, week 3 versus 2, week
6 versus 3, and week 8 versus 6 were selected for Gene
Ontology  (GO)  enrichment  (the  rest  of  the  GO  analysis
between age groups can be found in Appendix 2).
Each  functional  group  was  assigned  with  a  GO
enrichment score that was calculated using a χ2 test. A forest
plot  was  also  generated  to  show  the  percentage  of
differentially  expressed  genes  that  were  upregulated  and
downregulated for each functional group.
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1437RNA extraction and quantitative real time PCR (qPCR): We
used  qPCR  to  confirm  the  expression  of  genes  from  the
processes that were significantly involved in scleral growth
from postnatal week 1 to 2, week 2 to 3, week 3 to 6, and week
6 to 8 based on our GO analysis. In addition, we confirmed
that collagen genes (Col), epidermal growth factor receptor
(Egfr),  fibrillin  2  (Fbn2),  Fyn  proto-oncogene  (Fyn),  and
insulin-like growth factor 2 (Igf2) in 1-, 2-, 3-, 6-, and 8-week-
old sclera were differentially expressed at all time points.
Total  RNA  was  then  isolated  from  the  pooled
cryogenically-ground mouse sclera (n=60, six pooled sclera,
each from one-, two-, three-, six-, and eight-week-old mice;
this was repeated with two independent batches) using TRIzol
Reagent  (Invitrogen,  Carlsbad,  CA)  according  to  the
manufacturer’s instructions, with some modifications. After
homogenization,  0.2  ml  of  chloroform  was  added  and
vortexed for 3 min. The mixture was centrifuged at full speed
and the aqueous phase was collected. Isopropanol (0.5 ml of
100%) and 2 μl of glycogen (5 mg/ml; Ambion Inc.) was
added and centrifuged at full speed. Last, the RNA was further
purified  and  DNase  treated  using  an  RNeasy®  Mini  Kit
(Qiagen GmbH, Hilden, Germany). The RNA concentration
and quality were assessed as before.
Purified  RNA  (500  ng)  was  reverse-transcribed  into
cDNA using random primers and reagents from an iScript™
select cDNA synthesis kit (Bio-rad Laboratories, Hercules,
CA). The primers (see Appendix 3: Gene accession number
and  qPCR  primer  sequences)  were  designed  using  a
ProbeFinder 2.45 (Roche Applied Science, Indianapolis, IN).
qPCR was performed using a Lightcycler 480 Probe Master
(Roche  Applied  Science)  according  to  the  manufacturer’s
instructions. The reaction was run in a Lightcycler 480 (Roche
Applied  Science)  for  45  cycles  under  the  following
conditions: 95 °C for 10 s, 56 °C for 10 s, and 72 °C for 30 s.
qPCR  data  was  analyzed  using  the  comparative  Ct
(ΔΔCt) method as previously mentioned [10]. Briefly, the
average of target gene Ct was subtracted by the corresponding
average  18S  rRNA  Ct  value  to  obtain  a  ΔCt  value.
Subsequently,  the  ΔCt  value  was  subtracted  by  the  ΔCt
calibrator to obtain the ΔΔ Ct value. In this study, ΔCt values
of target genes in week 1 were used as a ΔCt calibrator to
determine the relative fold change in target genes between
weeks 1, 2, 3, 6, and 8. A total of two sets of cDNA were
synthesized from two separate batches of mice for running
qPCR, and a Student’s t-test was performed to determine the
significance of the relative fold change.
Pathway  analysis:  Ingenuity  Pathway  software  analysis
(IPA; Ingenuity® Systems, Redwood City, CA) was used to
generate  several  networks  using  differentially  expressed
transcript cluster lists for week 2 versus 1, week 3 versus 2,
week 6 versus 3, and week 8 versus 6. Similar significant
networks  (calculated  by  Fisher’s  exact  test;  p<0.05)  were
found in the scleral growth from week 1 to 2, week 2 to 3,
week 3 to 6, and week 6 to 8.
RESULTS
Significant  difference  between  various  age  groups:  All
samples were assessed for batch effects and normalized by the
batch removal tool using scan date as a factor. The variability
between  the  age  groups  was  evaluated  using  a  PCA  plot
(Figure 1A). It was shown that the individual scleral samples
from each time point were more related to each other than
samples from other time points, demonstrating that there were
significant differences in the gene expressions between the
various  age  groups.  ANOVA  was  performed  to  identify
significant  differentially  expressed  genes.  The  lists  of
differentially  expressed  transcript  clusters  between  age
groups were generated based on a selection criterion of ≥2
relative fold change at a false discovery rate of ≤5% (Table
1). Unexpectedly, the hierarchical clustering of all time points
showed that they did not cluster according to age (Figure 1B).
Week 2 versus 1 had the highest number of differentially
expressed  transcript  clusters  when  the  gene  expression
profiles from week 2, 3, 6, and 8 were compared to week 1.
Also, postnatal week 2 versus 1 had the highest number of
differentially expressed transcript clusters among all of the
possible age comparisons. This suggests that the majority of
gene expression changes during scleral postnatal development
occurred between postnatal week 1 and 2. Our microarray data
showed  that  week  8  versus  2  had  the  least  number  of
differentially expressed transcript clusters, indicating that the
gene expression profiles in the 2-week-old sclera were most
related to the 8-week-old sclera as compared to other weeks.
Since mouse eye development starts to reach a plateau from
postnatal week 8 onwards, we considered week 8-old sclera
to be the same as adult sclera. Therefore, it was surprising that
the gene expression profiles of 2-week-old sclera were quite
similar to adult sclera. However, there were still 749 transcript
clusters found to be differentially expressed between the week
2 and week 8 sclera.
Gene ontology (GO) analysis of postnatal week 1 to 2: GO
analysis was used to identify the main biologic processes that
were involved in scleral growth from postnatal week 1 and
week 2 sclera (Figure 2A). In general, biologic adhesion,
developmental  process,  establishment  of  localization  and
pigmentation  were  the  main  biologic  processes  involved.
Specifically, the most significant functions that were involved
in  week  1–2  scleral  development  were  visual  perception,
calcium ion binding, homophilic cell adhesion, cell-matrix
adhesion,  nervous  system  development,  eye  development,
cation  (sodium  and  calcium  ions)  transport  and
neurotransmitter transport. The expressions of genes in these
processes were mostly downregulated in week 2 sclera when
compared to week 1 sclera (Figure 2B).
GO  analysis  of  postnatal  week  2  to  3:  Establishment  of
localization,  biologic  adhesion,  pigmentation,  response  to
stimulus, and developmental process were the main biologic
processes involved in scleral growth from postnatal week 2 to
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14383 (Figure 2C). In particular, the most significant functions that
were involved in scleral growth from postnatal week 2 to 3
were visual perception, polysaccharide binding, extracellular
matrix binding, neurotransmitter transport, cation (sodium,
calcium  and  potassium)  transport,  cell-matrix  adhesion,
homophilic  cell  adhesion,  phototransduction,  detection  of
light stimulus, nervous system development and melanocyte
differentiation.  Their  gene  expressions  were  significantly
upregulated in scleral growth from postnatal week 2 to 3
(Figure 2D).
GO  analysis  of  postnatal  week  3  to  6:  Generally,
developmental  process,  cellular  component  organization,
establishment of localization and biologic adhesion were the
main biologic processes that were involved in scleral growth
from postnatal week 3 to 6 (Figure 2E). Particularly, the most
significant  functions  that  were  involved  in  scleral
development from postnatal week 3 to 6 were muscle system
process,  muscle  organ  development,  angiogenesis,  actin
binding, nucleosome assembly, collagen fibril organization,
oxygen transport, chloride ion transport, cell-matrix adhesion
and leukocyte adhesion. The expressions of genes that were
involved  in  angiogenesis,  actin  binding,  nucleosome
assembly,  collagen  fibril  organization,  oxygen  transport,
chloride ion transport, cell-matrix adhesion, and leukocyte
adhesion  were  mostly  downregulated,  whereas  the
expressions  of  genes  that  were  involved  in  muscle  organ
development  and  muscle  system  process  were  mostly
upregulated in week 6 sclera when compared to week 3 sclera
(Figure 2F).
Figure 1. Gene expression data analysis. A PCA plot of all samples was generated using Partek Genomic Suite 6.5 beta to assess the variability
of microarray data (Color for scan date and shapes for time points). It was shown that the individual scleral samples from each time point
were more related to each other than samples from other time points, demonstrating that there were significant differences in the gene
expressions between the various age groups (A). Furthermore, the mean of all time points was hierarchically clustered, and it was demonstrated
they did not cluster according to age (B).
TABLE 1. DIFFERENTIALLY EXPRESSED TRANSCRIPT CLUSTERS FOUND AMONG THE AGE GROUPS.
Comparison Differentially expressed transcript clusters*
Week 2 versus 1 4124
Week 3 versus 1 2538
Week 6 versus 1 2172
Week 8 versus 1 2554
Week 3 versus 2 1530
Week 6 versus 2 2400
Week 8 versus 2 749
Week 6 versus 3 2726
Week 8 versus 3 1809
Week 8 versus 6 1332
          *>2 relative fold change (p<0.05).
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1439GO analysis of postnatal week 6 to 8: Pigmentation, cellular
component  organization,  establishment  of  localization
(mainly bicarbonate, chloride ion, and sulfate transport) and
cellular  component  biogenesis  were  the  main  biologic
processes that were involved in scleral growth from postnatal
week 6 to 8 (Figure 2G). Particularly, the most significant
functions that were involved in scleral development from
postnatal week 6 to 8 were nucleosome assembly, protein-
DNA complex assembly, macromolecular complex assembly,
melanin  biosynthetic  process,  bicarbonate  transport  and
ribosome  biogenesis.  The  expressions  of  genes  that  were
involved  in  nucleosome  assembly,  protein-DNA  complex
assembly  and  macromolecular  complex  assembly  were
mostly upregulated, whereas the expressions of genes that
were involved in melanin biosynthetic process, bicarbonate
transport  and  ribosome  biogenesis  were  mostly
downregulated in week 8 sclera when compared to week 6
sclera (Figure 2H).
Gene expression of common reference genes: While the eye
undergoes  postnatal  development,  the  gene  expression  of
common  reference  genes  may  alter  [11].  Therefore,  we
examined the expressions of some common reference genes
to identify a suitable internal control for qPCR normalization.
Microarray  data  showed  that  there  were  some  significant
differences  in  the  gene  expression  of  glyceraldehyde-3-
phosphate  dehydrogenase  (Gapdh),  beta  actin,  (Actb),
hypoxanthine guanine phosphoribosyl transferase (Hprt), and
18S  rRNA  (18S  rRNA)  when  week  2,  3,  6,  and  8  were
compared  with  week  1  (Figure  3).  Nevertheless,  qPCR
analysis results showed that 18S rRNA had the lowest standard
deviation when its gene expression was compared among 1-,
2-, 3-, 6-, and 8-week-old mice (Table 2). Therefore, 18S
rRNA  was  subsequently  used  as  a  reference  gene  for
normalization of the qPCR data in this study.
Gene expression validation: We used quantitative real-time
PCR (qPCR) to confirm the expression of genes from the
processes that were significantly involved in scleral growth
from postnatal week 1 to 2, week 2 to 3, week 3 to 6, and week
6 to 8, based on GO analysis (Table 3 and Appendix 4). For
most  of  the  genes  analyzed  with  qPCR,  the  fold  change
regulation direction was similar to the microarray data, but for
genes Tgfβ2, keratin 17 (Krt 17), and histone cluster 1, H2bc
Figure 2. GO analysis of sclera postnatal development. GO analysis was used to identify that the main biologic processes that were involved
in scleral growth from postnatal week 1 to 2 (A), week 2 to 3 (C), week 3 to 6 (E), and week 6 to 8 (G), respectively. Furthermore, forest
plots were generated to analyze the percentage of genes that were either upregulated or down-regulated in each of the biologic processes that
was involved in scleral growth from postnatal week 1 to 2 (B), week 2 to 3 (D), week 3 to 6 (F), and week 6 to 8 (H), respectively.
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1440(Hist1h2bc), a relatively low fold change of less than 1.4 was
reported. As the fold change was relatively low, we are unable
to confirm the result obtained from the microarray data.
On the other hand, relative fold change results obtained
from qPCR analysis and microarray for some genes were
relatively different. This was observed for genes neurogenic
differentiation 1 (Neurod1) and titin (Ttn). This could be due
to differences in the normalization methods used between the
two different techniques. A global normalization technique
was employed when analyzing the microarray data, but this is
not possible when doing qPCR analysis. Also, in a study by
Etienne et al., an increase in distance between the PCR primers
and microarray probes for a given gene resulted in a decrease
in the correlation of results between the two different methods
[12]. It is thus suggested that primers be designed as close as
possible to the distance amplified by the microarray probes.
Also,  we  compared  the  gene  expression  of  Col-1a2
(collagen, type I, alpha 2), -3a1 (collagen, type III, alpha 1),
-5a2 (collagen, type V, alpha 2), -6a3 (collagen, type VI, alpha
3),  epidermal  growth  factor  receptor  (Egfr),  fibrillin  2
(Fbn2), Fyn proto-oncogene (Fyn), and insulin-like growth
factor 2 (Igf2) in one-, two-, three-, six-, and eight-week-old
sclera in both the qPCR and microarray experiments (Figure
4). The fold changes in the gene expressions obtained from
the  microarray  results  were  higher  than  the  relative  fold
changes obtained from the qPCR results in some cases. This
might be due to the difference in the detection methods and
probe design between the microarray chips and qPCR. Each
gene was represented by approximately 27 probes that spread
across the full length of the gene on the GeneChip® Mouse
Gene 1.0 ST Array, and thus the final fold change obtained
from the microarray was an average expression change of
these  probe  regions.  In  contrast,  the  relative  fold  change
obtained from qPCR represented the change in expression of
a selected gene region. Nevertheless, the gene expression
profiles obtained from the microarray data showed a similar
gene regulation direction as compared to the gene expression
profiles obtained from qPCR.
Ingenuity pathway analysis (IPA): We used IPA to determine
similar significant networks found between scleral growth
from week 1 to 2, week 2 to 3, week 3 to 6 and week 6 to 8.
It was found that peroxisome proliferative activated receptor,
gamma,  coactivator  1a  (Ppargc1a)  was  involved  in  the
networks generated from the lists of differentially expressed
transcript clusters for week 2 versus 1, week 3 versus 2, week
6  versus  3,  and  week  8  versus  6.  This  indicated  that
Ppargc1a might play a role in regulating scleral growth from
postnatal week 1 to 8, as the gene expression of Ppargc1a
varied significantly during sclera growth from week 1 to 2,
Figure  3.  Gene  expression  of  4
housekeeping  genes  from  microarray
data.  Mean  relative  signal  (n=6)  and
standard  deviation  of  4  housekeeping
genes  were  calculated  and  plotted  to
compare  their  gene  expression  from
week 1, 2, 3, 6, and 8. ANOVA analysis
was  performed  to  compare  the  gene
expression  of  different  weeks  against
week 1 gene expression. * represents
p<0.05. It was shown that there were
some significant differences in the gene
expression  of  glyceraldehyde-3-
phosphate  dehydrogenase  (Gapdh),
beta actin (Actb), hypoxanthine guanine
phosphoribosyl transferase (Hprt), and
18S rRNA(18S rRNA) when week 2, 3,
6, and 8 were compared with week 1.
TABLE 2. GENE EXPRESSION OF HOUSEKEEPING GENES BASED ON CT VALUE.
Genes Average Ct
1 calue among week 1, 2, 3, 6,
and 8
Standard deviation
18s rRNA 10.0 0.37
Gapdh 22.6 0.72
Hprt 27.0 0.63
Actb 20.1 0.66
          1A higher Ct value would indicate a lower level of gene expression.
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1441week  2  to  3,  week  3  to  6,  and  week  6  to  8  (Table  4).
Furthermore, Ppargc1a sometimes interacted with a different
set of genes at different scleral growth stages. We also looked
into the expression of Ppargc1a using qPCR. However, the
fold change values obtained from qPCR analysis were lower
as compared to the fold change values that were obtained from
the microarray data. Particularly, the fold change comparison
for week 1 versus 2 and week 3 versus 6 were −1.1 and +1.1
respectively. On the other hand, week 2 versus 3 comparison
as well as week 6 versus 8 comparison of Ppargc1a expression
showed a similar gene regulation direction, as compared to
the gene expression profile obtained from the microarray.
As depicted in the associated network generated by IPA
(Figure 5A), the gene expressions of Ppargc1a, malic enzyme
1,  NADP  (+)-dependent,  cytosolic  (Me1),  cytochrome  c,
somatic  (Cycs),  NADH  dehydrogenase  (ubiquinone)  Fe-S
protein 1(Ndufs1), creatine kinase, mitochondrial 2 (Ckmt2),
and carnitine palmitoyltransferase 1b, muscle (Cpt1b) were
downregulated during scleral growth from postnatal week 1
to  2.  In  addition,  other  downstream  players  such  as
peroxisome  proliferative  activated  receptor,  gamma,
coactivator 1b, and zinc finger E-box binding homeobox 2
were also significantly downregulated during scleral growth
from postnatal week 1 to 2.
During scleral growth from postnatal week 2 to 3 (Figure
5B), the gene expression of Ppargc1a and uncoupling protein
2  (mitochondrial,  proton  carrier)  were  upregulated.
Furthermore, downstream players such as microphthalmia-
associated transcription factor and visual system homeobox 2
were also upregulated during scleral growth from postnatal
week 2 to 3.
The  network  associated  with  scleral  growth  from
postnatal week 3 to 6 (Figure 5C) showed that Ppargc1a was
further upregulated from postnatal week 3 to 6. In addition,
the  gene  expressions  of  Me1,  Cycs,  Ckmt2,  Cpt1b,  and
Ndufs1 were also upregulated from postnatal week 3 to 6.
Furthermore, hexamethylene bis-acetamide inducible 1 gene
expression was upregulated while the gene expressions of
placental growth factor and Fms-like tyrosine kinase-1 were
downregulated during scleral growth from postnatal week 3
to 6.
Based on the network generated by IPA (Figure 5D), the
gene  expressions  of  Ppargc1a,  Cycs,  and  Me1  were
downregulated during scleral growth from postnatal week 6
to 8.
DISCUSSION
Differential gene expression patterns detected as early as
week 1: Many gene expression studies on eye diseases have
been performed using adult mice (≥6 weeks old). However,
we have illustrated that changes in gene expression levels in
the mouse eye can occur as early as postnatal week 1. Our
microarray data showed that the week 2 versus 1 comparison
TABLE 3. COMPARISON OF RELATIVE FOLD CHANGE OF GENES FROM PROCESSES THAT WERE SIGNIFICANTLY INVOLVED IN SCLERAL
GROWTH.
Comparison Genes GO term Microarray (fold
change)
qPCR (relative fold
change)
Week 2 vs 1 Col3a1 collagen fibril
organization
−2.7 −1.5
  Tgfβ 2 eye development −2.6 −1.3
  Neurod1 eye development −26.5 −15.4
Week 3 vs 2 Ctgf calcium ion transport
into cytosol
4.2 4.3
  Tgfβ 1 Regualtion of sodium ion
transport
2.0 1.6
  Dsg1a homophilic cell adhesion 2.7 1.6
Week 6 vs 3 Ttn cardiac muscle tissue
morpogenesis
26.5 2.0
  Myo 18b cardiac muscle fiber
development
4.1 1.4
  Col 3a1 collagen fibril
organization
−2.1 −2.1
Week 8 vs 6 Myo 5a pigmentation −2.1 −1.4
  Krt 17 intermediate filament
cytoskeleton
organization
3.1 1.2
  Hist1h2bc nucleosome assembly 2.8 1.2
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1442Figure 4. qPCR analysis of collagen genes, Egfr, Fbn2, Fyn, and Igf2. The gene expression profiles of Col-1a2, -3a1, -5a2, -6a3, and Egfr,
Fbn2, Fyn, and Igf2 in week 1, 2, 3, 6, and 8 were compared the microarray data. It was demonstrated that the expression profiles of these
genes obtained from the microarray data showed a similar gene regulation direction, as compared to the expression profiles obtained from
qPCR.
Molecular Vision 2012; 18:1436-1448 <http://www.molvis.org/molvis/v18/a150> © 2012 Molecular Vision
1443generated  the  highest  number  of  differentially  expressed
genes when all weeks were compared, indicating that most of
the gene expression change occur during the eye opening
process  that  occurs  around  postnatal  day  12–14.  Indeed,
Barathi et al. [13,14] had reported that the growth rate of
mouse and rabbit eye axial length was the highest from week
1 to 2. Hence, we propose that the gene expression profiles of
eye diseases should be studied as early as postnatal week 1 to
ensure  that  all  altered  genetic  changes  during  disease
development are detected.
Differential gene expression patterns were not age dependent:
Previously,  Dorrell  et  al.  [15]  examined  the  global  gene
expression  of  the  developing  postnatal  mouse  retina.  The
hierarchical clustering of all time points (postnatal day 0, P4,
P8, P10, P12, P14, P21, and P42) showed that they did cluster
according  to  age  during  retinal  postnatal  development.
However, our results showed that changes in gene expression
TABLE 4. PPARGC1A GENE EXPRESSION DURING SCLERA POSTNATAL DEVELOPMENT.
Scleral growth Microarray fold change qPCR relative fold change
Week 1 to 2 (Week 2 vs 1) −6.7 −1.1
Week 2 to 3 (Week 3 vs 2) 2.7 2.5
Week 3 to 6 (Week 6 vs 3) 2.1 1.1
Week 6 to 8 (Week 8 vs 6) −3.2 −1.8
Figure 5. Identification of network with common gene interactions involved in postnatal sclera development using IPA. IPA was used to
generate several networks using differentially expressed transcript cluster list from week 2 versus 1 (A), week 3 versus 2 (B), week 6 versus
3 (C), and week 8 versus 6 (D). The network from each differentially expressed transcript cluster list with common gene interactions (calculated
by Fisher’s exact test; p<0.05) was identified. Ppargc1a was the only common gene that was involved in the networks generated from
differentially expressed transcript cluster list of week 2 versus 1, week 3 versus 2, week 6 versus 3, and week 8 versus 6, respectively. Red
color represents the upregulated genes and green color represents the down-regulated genes from micro array analysis. Intensity of the color
indicates the gene expression level.
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1444at various time points (postnatal week 1, 2, 3, 6, and 8) during
scleral postnatal development was not dependent on age. This
variation might be caused by the differences in cell type and
function between the sclera and the retina. The retina contains
several neuronal types of cells and is mainly responsible for
the processing of light signals through phototransduction. On
the other hand, the sclera mainly contains fibroblasts that
produce and maintain the extracellular matrix that gives the
sclera its resilience. Furthermore, these discrepancies in the
results might be due to the difference in the type of microarray
chips used. We used GeneChip® Mouse Gene 1.0 ST Arrays
(whole  transcript-based  expression  array  design),  whereas
Dorrell et al. used the Murine Genome U74v2 genechip (3′-
based expression array design) [15]. In general, the whole
transcript-based  expression  array  design  provides  better
coverage and a more accurate view of the total transcription
at each genomic locus than the 3′-based expression array
design does. Therefore, the difference in the array design
might also cause slight variations in the results.
Expression  of  collagen  genes  in  postnatal  mouse  scleral:
qPCR  analysis  on  postnatal  scleral  samples  revealed  a
downregulation of collagen gene expression with the increase
in  postnatal  sclera  age.  This  result  correlates  with  the
microarray data. One study reported that mRNA levels of
collagen (Col) I, III, and VI were the highest on postnatal day
5 as compared to postnatal day 20, and at 4, 9, and 15 months
[16]. In this study, it was demonstrated that although the
mRNA levels of Col I, III, and VI decreased with increasing
age, their proteins were widely distributed in the aging eyes,
suggesting  a  low  turnover  rate  of  the  collagens  [16].
Furthermore, Lee and Davidson [17] reported that the half-life
of collagens was longer in older rabbit eyes, and thus collagen
synthesis might be reduced in older age. Our results correlated
with  these  studies  and  showed  that  the  mRNA  levels  of
Col-1a2, -3a1, -5a2, and -6a3 were the highest in week 1 as
compared with week 2, 3, 6, and 8. Therefore, this suggests
that the mRNA levels of these collagens in sclera might reduce
with increasing age, due to the increasing half-life of their
protein.
Expression of Igf2 in postnatal mouse sclera: Kane et al.
[18] previously reported that the gene expressions of Igf2 were
also downregulated in postnatal day 60 bovine keratocytes as
compared to postnatal day 4. Furthermore, Igf2 were also
previously demonstrated to promote synthesis of collagen
type I [19]. In agreement with these findings, our results also
showed that the gene expression of both Igf2 and Col-1a2
were  downregulated  from  week  1  to  8.  Therefore,  we
speculate that the downregulation of the Igf2 gene might lead
to a decrease in mRNA levels of Col-1a2 in scleral postnatal
development from week 1 to 8.
Expression of Fbn2 in postnatal mouse sclera: The expression
of Fbn2 in sclera was found to be downregulated with an
increase in postnatal age (Figure 4). The results correlated
with a microarray study on mouse conjunctiva by Gupta et al.
[20], whereby both Igf2 and Fbn2 were reported to be among
the most decreased transcripts when comparing postnatal day
20 and 9 in conjunctival tissue. In addition, in a paper by
Jordan  et  al.  [21],  Fbn2  expression  was  described  to  be
relatively  robust  during  early  fetal  development,  but
expression  declined  to  low  levels  in  postnatal  tissue,
suggesting it might regulate elastic fiber assembly. Fbn2 may
also act as a mediator for growth signaling by interacting with
latent  transforming  growth  factor  beta  binding  protein  3
(Ltbp-3) and latent transforming growth factor beta binding
protein 4 (Ltbp-4) to regulate the targeting of transforming
growth factor β (Tgf-β) in the ECM [22].
Expression of Egfr in postnatal mouse sclera: Growth factors
promote the proliferation of sclera fibroblasts, and thus are
important  to  the  growth  of  the  sclera.  Hackel  et  al.  had
previously reported that Egf was involved in ECM production
[23].  In  our  study,  Egfr  gene  expression  increased
progressively from week 1 to 8, and the highest expression
was reported in week 2, although the highest expression for
qPCR  analysis  was  reported  to  be  at  week  6.  Egfr  is  an
important  gene  whose  key  role  includes  regulating  the
proliferation of various cell types [24]. Thus, Egfr might play
a role in promoting scleral fibroblast growth, and hence the
overall ocular growth, from week 1 to 8. In addition, our study
further added to the importance of Egfr in postnatal scleral
development  whereby  the  lack  of  Egfr  in  mice  proved
embryonically lethal [24].
Expression of Fyn in postnatal mouse sclera: The expression
of Fyn fluctuated during development, but the expression was
downregulated twofold at the end of eight weeks as compared
to expression levels in week 1. In a paper by Su et al. [25],
fibroblasts that were inactivated for receptor protein tyrosine
phoshatase-α  caused  impairment  in  the  tyrosine  kinase
activity of both c-Scr and Fyn. As a result, deficiencies in
integrin-mediated signaling responses were exhibited. This
implies  that  Fyn  gene  had  a  role  in  regulating  integrin
signaling,  and  would  be  crucial  for  cell  growth  and
proliferation,  considering  that  integrin  mediates  the
attachment of cell to the tissue surrounding it [25].
Expression  of  Ppargc1a  in  postnatal  mouse  sclera:
Ppargc1a is a multifunctional transcriptional coactivator and
has the ability to interact with different transcription factors
in a tissue-specific manner. It plays a significant role in the
regulation  of  several  processes,  such  as  mitochondrial
biogenesis, adaptive thermogenesis, gluconeogenesis, fatty
acid β-oxidation, fiber-type switching and heart development
[26-28]. In this study, we suggest that Ppargc1a might play a
role in scleral development from postnatal week 1 to 8 using
IPA. Interestingly, the gene expression of Ppargc1a varied
significantly  during  scleral  growth  from  week  1  to  8.
Furthermore, Ppargc1a interacted with a different set of genes
at different scleral growth stages. Previously, it had been
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1445reported that human sclera shared common gene expression
profiles with cartilage and maintained chondrogenic potential
[29]. Indeed, Tsai et al. identified a group of multipotent
mesenchymal stem cells residing in sclera and had the ability
to differentiate to adipogenic, chondrogenic and neurogenic
lineages  [30].  As  Ppargc1a  had  been  shown  to  act  as  a
coactivator for SRY-related high mobility group-Box gene 9
and  to  regulate  chondrogenesis  [31],  we  propose  that
Ppargc1a might also act as a regulator for scleral postnatal
development.  Furthermore,  Ppargc1a  might  regulate
development by interacting with a different set of genes at
different scleral growth stages.
Relative fold change values obtained from qPCR analysis
of Ppargc1a was significantly lower than values obtained
from microarray. We are able to confirm the expression of
Ppargc1a in comparing week 2 versus 3 as well as week 6
versus 8. However, we were unable to confirm Ppagrc1a
expression  for  week  2  versus  1  and  week  3  versus  6
comparisons. In particular, the fold change in week 2 versus
1 was reduced from −6.7 to −1.1, and week 6 versus 3 was
reduced from 2.1 to 1.1. Thus, we are unable to confirm the
result for these two weeks, as the fold change values obtained
was not significant. This might be due to the difference in
detection methods between the microarray chips and qPCR.
Nevertheless, the gene expression of Ppargc1a still varied
during scleral growth from week 1 to 8.
In conclusion, we examined the gene expression profiles
of  scleral  postnatal  development  from  week  1  to  8.  The
hierarchical clustering of all time points showed that they did
not cluster according to age. Despite a short time interval
between week 1 and 2, week 2 versus 1 data showed the
highest number of differentially expressed transcript clusters
when the gene expression profiles in weeks 2, 3, 6, and 8 were
compared  to  week  1.  Therefore,  we  suggest  that  gene
expression  of  eye  diseases  should  be  studied  as  early  as
postnatal week 1 to ensure that all altered changes during
disease development are detected. In addition, we identified
Ppargc1a as a possible player in scleral development from
postnatal week 1 to 8 using IPA. Hence, we propose that
Ppargc1a might also act as a regulator for postnatal scleral
development by interacting with a different set of genes at
different  scleral  growth  stages.  Further  proteomics
investigation will provide a clearer view on the role of the
genes  that  are  involved  in  different  stages  of  postnatal
development  by  confirming  their  protein  expression  and
localization.
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1447Appendix 1. Differentially expressed transcript clusters.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 2. Gene ontology enrichment analysis of all week comparisons.
To access the data, click or select the words “Appendix
2.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 3. Gene accession number and qPCR primer sequences.
To access the data, click or select the words “Appendix
3.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 4. Mean Ct values of all validated genes.
To access the data, click or select the words “Appendix
4.” This will initiate the download of a compressed (pdf)
archive that contains the file.
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